Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
65.33
+4.04 (6.59%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $98 | Buy | Maintains | $98 | +50.01% | Aug 4, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $97 | Buy | Maintains | $97 | +48.48% | Jul 21, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $90 → $89 | Buy | Maintains | $90 → $89 | +36.23% | Jul 21, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 14, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +45.42% | Jul 13, 2026 |
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +53.07% | Jul 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $88 | Buy | Reiterates | $88 | +34.70% | Jul 9, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $90 → $89 | Buy | Maintains | $90 → $89 | +36.23% | Jul 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.